| Active ingredient (INN) | Olanzapin |
|---|---|
| Brand names | Zyprexa |
| Therapeutic category | Auto-created by Bundesinstitut für Arzneimittel und Medizinprodukte — Lieferengpässe scraper |
| Controlled substance | No |
|---|
| Marketing-authorisation holders | TEVA PHARMACEUTICALS USA, INC., PAI Holdings, LLC dba PAI Pharma, Pharmaco Australia Ltd |
|---|
| Registrations on file | 28 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| APO-OLANZAPINE olanzapine | 5 mg | — | 🇦🇺 AU | — | Active |
| APO-OLANZAPINE olanzapine | 7.5 mg | — | 🇦🇺 AU | — | Active |
| APO-OLANZAPINE olanzapine | 10 mg | — | 🇦🇺 AU | — | Active |
| OLANZA olanzapine | 5 mg | — | 🇦🇺 AU | — | Active |
| OLANZA olanzapine | 2.5 mg | — | 🇦🇺 AU | — | Active |
| PRYZEX olanzapine | 10 mg | — | 🇦🇺 AU | — | Active |
| Olanzapine | 5mg/1 | tablet | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Olanzapine | 10mg/1 | tablet | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Olanzapine | 15mg/1 | tablet | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Olanzapine | 20mg/1 | tablet | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Olanzapine and Fluoxetine | 25; 3mg/1; mg/1 | capsule | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Olanzapine and Fluoxetine | 25; 6mg/1; mg/1 | capsule | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Olanzapine and Fluoxetine | 50; 6mg/1; mg/1 | capsule | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Olanzapine and Fluoxetine | 25; 12mg/1; mg/1 | capsule | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Olanzapine and Fluoxetine | 50; 12mg/1; mg/1 | capsule | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |